AB Science S.A. AB Science S.A.

AB Science S.A.

AB

Rank in Stocks #22933
AB Science S.A. is a pharmaceutical company dedicated to the discovery,... AB Science S.A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors for applications in both human and animal health. Its primary drug candidate, masitinib, a tyrosine kinase inhibitor, is currently undergoing late-stage (Phase III) clinical investigations for a range of serious conditions including prostate cancer, pancreatic cancer, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Alzheimer's disease, severe asthma, and mastocytosis. Additionally, masitinib is being evaluated in Phase II clinical trials for the treatment of Covid-19. The company's pipeline also features AB8939, a synthetic microtubule destabilizer aimed at treating acute myeloid leukemia, and AB20001, which is in Phase 2 trials to assess the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients experiencing moderate to severe COVID-19. Masitinib is sold under the brand name Masivet in the European market. AB Science S.A. was founded in 2001 and is based in Paris, France.
Share Price
$0.69235838
Last synced: 2026-11-11
Market Cap
$46.96M
Change (1 day)
15.53%
Change (1 year)
-48.67%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for AB Science S.A. (AB)
EPS as of June 2026 TTM: $-0.09
According to AB Science S.A.'s latest financial reports, its current EPS (TTM) is $-0.09. At the end of 2025 the company had an EPS of $-0.03, an increase over its 2024 EPS of $-0.16.
EPS history for AB Science S.A. from 2009 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.09 195.67%
2025 $-0.03 -80.91%
2024 $-0.16 -41.16%
2023 $-0.27 -14.72%
2022 $-0.31 -8.80%
2021 $-0.34 -17.63%
2020 $-0.41 -32.90%
2019 $-0.62 -22.15%
2018 $-0.79 -11.91%
2017 $-0.90 9.65%
2016 $-0.82 -3.09%
2015 $-0.85 42.84%
2014 $-0.59 -4.19%
2013 $-0.62 37.97%
2012 $-0.45 11.76%
2011 $-0.40 -6.19%
2010 $-0.43 10.09%
2009 $-0.39 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 -6,898.08%
DE
$6.01 -6,873.17%
DE
$1.53 -1,828.18%
JP
$3.66 -4,226.27%
CH
$0.45 -607.33%
IL

Questions about AB Science S.A.'s earnings per share (EPS)

What is AB Science S.A.'s earnings per share (EPS)?

AB Science S.A.'s earnings per share (EPS) over the last twelve months is $-0.09, as of Jun 2026.

What was AB Science S.A.'s earnings per share (EPS) in 2025?

In 2025, AB Science S.A.'s earnings per share (EPS) was $-0.03, compared with $-0.16 in 2024.

How has AB Science S.A.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, AB Science S.A.'s earnings per share (EPS) was highest in 2025 ($-0.03) and lowest in 2020 ($-0.41).

How does AB Science S.A.'s earnings per share (EPS) compare with similar companies?

AB Science S.A.'s earnings per share (EPS) ($-0.09) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.